1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Maʻemaʻe >98.0% (HPLC) Brexpiprazole Intermediate Factory

ʻO ka wehewehe pōkole:

1-(1-Benzothiophen-4-yl) piperazine Hydrochloride

CAS: 913614-18-3

Maʻemaʻe: >99.0% (HPLC)

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Ka waena o Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

ʻO Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-hoʻokahi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3

Na Waiwai Kemika:

Inoa Kimia	1-(1-Benzothiophen-4-yl) piperazine Hydrochloride
Nā huaʻōlelo like	Brexpiprazole Intermediate 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride
Helu CAS	913614-18-3
Helu CAT	RF-PI1034
Kūlana Kūʻai	Ma ka waihona, ka mana hana 100MT / makahiki
ʻĀpana Molekala	C12H15ClN2S
Kaumaha Molecular	254.7789
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a hiki i ka pauda keʻokeʻo
ʻIkepili	Kūlike ka manawa paʻa o ka laʻana me ka maʻamau kuhikuhi
Maʻemaʻe / Kaʻina Hanana	>99.0% (HPLC)
Nalo ma ka maloo	<0.50%
Wai (KF)	<0.50%
Koena ma ka Ignition	<0.20%
Na mea pili	(HPLC)
ʻO kēlā me kēia haumia kanaka	<0.50%
Huina paumaele	<1.00%
Infrared Spectrum	Kūlike i ka hoʻolālā
Proton NMR Spectrum	Kūlike i ka hoʻolālā
Kūlana hoʻāʻo	ʻOihana Kūlana
Hoʻohana	Ka waena o Brexpiprazole (CAS: 913611-97-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

FAQ:

Noi:

ʻO 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride (CAS: 913614-18-3) he mea waena o Brexpiprazole (CAS: 913611-97-9).ʻO Brexpiprazole kahi ʻano antipsychotic atypical.ʻO ia ka dopamine D2 receptor partial agonist.Ma ke ʻano he modulator hana serotonin-dopamine, hiki ke hoʻohana ʻia no ka mālama ʻana i ka schizophrenia, a no ka lāʻau hoʻohui no ke kaumaha.Hiki iā ia ke hāʻawi i ka maikaʻi a me ka ʻae ʻana ma luna o nā lāʻau lapaʻau adjunctive i hoʻokumu ʻia no ka maʻi depressive maʻi (MDD).Hōʻike ka lāʻau lapaʻau i kahi ʻano lāʻau pharmacological kūʻokoʻa, e hana ana ma ke ʻano he agonist ʻāpana o ka serotonin 5-HT1A a me ka dopamine D2 receptors a ma ke ʻano he antagonist piha o 5-HT2A a me noradrenaline α1B / 2C receptors, me ka subnanomolar binding affinity.ʻO ka lāʻau lapaʻau, i hoʻomohala ʻia e Otsuka a me Lundbeck, ua ʻae ʻia ma 2015 e ka FDA no ka mālama ʻana i ka schizophrenia a ma ke ʻano he lāʻau hoʻohui no ke kaumaha.